Hims & Hers Acquires MedisourceRx from Nivagen Pharmaceuticals
September 12, 2024
Hims & Hers has acquired MedisourceRx, the FDA-registered 503B outsourcing facility and business unit of Nivagen Pharmaceuticals. Bourne Partners served as exclusive financial adviser to Nivagen; proceeds from the sale will allow Nivagen to complete a sterile injectables facility in California and advance its pipeline.
- Buyers
- Hims & Hers
- Targets
- MedisourceRx
- Sellers
- Nivagen Pharmaceuticals
- Industry
- Pharmaceuticals
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.